Kidney disease — all decisions

The Board remands the issues of entitlement to service connection for hypertension and chronic kidney disease due to pre-decisional duty to assist errors.

The Board granted readjudication of the claim for service connection for the cause of the Veteran's death due to new and relevant evidence being submitted after the prior denial.

The Board denied service connection for the cause of the Veteran's death due to renal cell cancer, finding no evidence that it was related to his military service.

The Board granted service connection for hypertension, mild renal insufficiency as secondary to hypertension, residuals of right inguinal hernia repair, and a gastrointestinal disorder including GERD and peptic ulcer. The claims for colitis, neck disability, right shoulder disability, and left shoulder disability were denied.

The Board remands the matter to obtain additional private treatment records and a VA examination to determine if the Veteran's service-connected PTSD caused or aggravated his death.

The Board denied service connection for multiple conditions, including right and left shoulder pain, nephrolithiasis, bilateral hearing loss, obstructive sleep apnea, cervical spine degenerative disc disease, and upper extremity radiculopathy. The claims were not granted.

The Board denied service connection for chronic sinusitis, hyperlipidemia, diabetes mellitus, type II, diabetic retinopathy, erectile dysfunction, kidney cancer, and coronary artery disease.

The Board remands the issue of entitlement to service connection for kidney disease due to a lack of an opinion regarding the Veteran's kidney disease in relation to his exposure to toxins at Camp LeJeune.

The Board remands the case to obtain a medical opinion addressing whether the Veteran's service-connected PTSD caused or aggravated his cardiovascular diseases, which were listed as contributing causes of death.

The Board remands the case for a VA examination to determine if the Veteran's clear cell renal cell carcinoma is related to his in-service herbicide exposure.

The Veteran's renal cell carcinoma, status-post left total nephrectomy with chronic kidney disease causes him to be unable to follow a substantially gainful occupation, and he is granted a TDIU effective August 10, 2022.

The Board denied an initial compensable rating for chronic kidney disease as the evidence did not show a GFR from 45 to 59 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months.

The Board has dismissed all appeals for service connection and a rating in excess of 10 percent for rhinitis.

The Board denied service connection for multiple conditions, including residuals of a rib injury, left ankle injury, lower extremity sciatica, hypertension, blurred vision, chest pain, and kidney disease, as there was no current diagnosis or evidence of related functional impairment.

The Board granted service connection for kidney cancer and liver cancer, both due to exposure to contaminated water at Camp Lejeune during active military service.

The Board denied the Veteran's claims for increased ratings and service connection, remanding some issues for further development.

The Board denied increased ratings for kidney cancer, kidney removal, painful periumbilical scar status post partial nephrectomy, and surgical scars status post partial nephrectomy. The effective date of service connection was granted as May 13, 2023.

The Board denied service connection for eczema, hypertension, basal cell carcinoma, and renal cell carcinoma and chronic kidney disease as the evidence did not support a finding that these conditions were related to the Veteran's active service.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board dismissed the claims for service connection for right and left knee disabilities, denied service connection for bilateral flat feet, respiratory disability, vertigo, and a compensable rating for bilateral hydrocele. The claim for service connection for kidney disability was granted, and a 10 percent rating for hypertension was assigned.